Boundless Bio, Inc. (BOLD)
2.32
-0.06
(-2.52%)
USD |
NASDAQ |
Nov 20, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
Boundless Bio Shareholders Equity (Quarterly) : 61.72M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 61.72M |
| June 30, 2026 | 65.98M |
| March 31, 2026 | 86.38M |
| December 31, 2025 | 98.65M |
| September 30, 2025 | 110.17M |
| June 30, 2025 | 122.69M |
| March 31, 2025 | 136.59M |
| December 31, 2024 | 150.64M |
| Date | Value |
|---|---|
| September 30, 2024 | 165.08M |
| June 30, 2024 | 179.25M |
| March 31, 2024 | 106.43M |
| December 31, 2023 | -127.08M |
| September 30, 2023 | -116.04M |
| June 30, 2023 | -103.87M |
| March 31, 2023 | |
| December 31, 2022 | -81.70M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.59M |
| Total Liabilities (Quarterly) | 1.872M |
| Current Ratio | 33.97 |
| Net Debt Paydown Yield | 17.07% |